Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Pituitary Neoplasms × Aminolevulinic Acid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioma 3 Brain Neoplasms 2 Pituitary Neoplasms 1 Neuroectodermal Tumors 1 Neoplasms, Neuroepithelial 1 Neoplasms 1 Neoplasm, Residual 1 Keratosis, Actinic 1 Central Nervous System Neoplasms 1

Interventions

Surgical Procedures, Operative 3 Surveys and Questionnaires 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy 1 Radiosurgery 1 Human Growth Hormone 1 Growth Hormone 1 Dosage Forms 1 Continuous Glucose Monitoring 1 Aminolevulinic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04390802 2021-02-24

A Pilot Study of 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Pituitary Adenomas

Massachusetts General Hospital

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡